MAPK-interacting kinase 1 regulates platelet production, activation, and thrombosis.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
08 12 2022
Historique:
accepted: 20 07 2022
received: 18 01 2022
pubmed: 6 8 2022
medline: 15 12 2022
entrez: 5 8 2022
Statut: ppublish

Résumé

The MAPK-interacting kinase (Mnk) family includes Mnk1 and Mnk2, which are phosphorylated and activated in response to extracellular stimuli. Mnk1 contributes to cellular responses by regulating messenger RNA (mRNA) translation, and mRNA translation influences platelet production and function. However, the role of Mnk1 in megakaryocytes and platelets has not previously been studied. The present study investigated Mnk1 in megakaryocytes and platelets using both pharmacological and genetic approaches. We demonstrate that Mnk1, but not Mnk2, is expressed and active in human and murine megakaryocytes and platelets. Stimulating human and murine megakaryocytes and platelets induced Mnk1 activation and phosphorylation of eIF4E, a downstream target of activated Mnk1 that triggers mRNA translation. Mnk1 inhibition or deletion significantly diminished protein synthesis in megakaryocytes as measured by polysome profiling and [35S]-methionine incorporation assays. Depletion of Mnk1 also reduced megakaryocyte ploidy and proplatelet forming megakaryocytes in vitro and resulted in thrombocytopenia. However, Mnk1 deletion did not affect the half-life of circulating platelets. Platelets from Mnk1 knockout mice exhibited reduced platelet aggregation, α granule secretion, and integrin αIIbβ3 activation. Ribosomal footprint sequencing indicated that Mnk1 regulates the translation of Pla2g4a mRNA (which encodes cPLA2) in megakaryocytes. Consistent with this, Mnk1 ablation reduced cPLA2 activity and thromboxane generation in platelets and megakaryocytes. In vivo, Mnk1 ablation protected against platelet-dependent thromboembolism. These results provide previously unrecognized evidence that Mnk1 regulates mRNA translation and cellular activation in platelets and megakaryocytes, endomitosis and thrombopoiesis, and thrombosis.

Identifiants

pubmed: 35930749
pii: S0006-4971(22)01002-3
doi: 10.1182/blood.2022015568
pmc: PMC9918849
doi:

Substances chimiques

RNA, Messenger 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2477-2489

Subventions

Organisme : NHLBI NIH HHS
ID : K08 HL153953
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002538
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL145237
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL130541
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL142804
Pays : United States
Organisme : CSRD VA
ID : I01 CX001696
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL163019
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL155856
Pays : United States
Organisme : NIA NIH HHS
ID : K01 AG059892
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG048022
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022 by The American Society of Hematology.

Références

Semin Hematol. 2010 Jul;47(3):220-6
pubmed: 20620432
Mol Cell Biol. 2006 Aug;26(15):5744-58
pubmed: 16847328
Mol Cell Biol. 1999 Mar;19(3):1871-80
pubmed: 10022874
J Thromb Haemost. 2017 Dec;15(12):2408-2418
pubmed: 28981191
Vox Sang. 2010 Aug 1;99(2):112-22
pubmed: 20345520
Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):13984-90
pubmed: 20679220
Blood. 2010 May 6;115(18):3801-9
pubmed: 20086251
Blood. 2016 Mar 17;127(11):1468-80
pubmed: 26744461
J Thromb Haemost. 2021 May;19(5):1319-1330
pubmed: 33587773
J Thromb Haemost. 2003 Jul;1(7):1580-6
pubmed: 12871294
Mol Oncol. 2018 Nov;12(11):1856-1870
pubmed: 30221473
EMBO J. 1997 Apr 15;16(8):1909-20
pubmed: 9155017
J Exp Med. 2006 Oct 30;203(11):2433-40
pubmed: 17060476
Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):s17-24
pubmed: 18296586
Blood Adv. 2021 May 11;5(9):2362-2374
pubmed: 33944898
J Biol Chem. 1995 Sep 15;270(37):21684-8
pubmed: 7665584
Br Med Bull. 1955;11(1):21-7
pubmed: 13230470
Adv Prostaglandin Thromboxane Res. 1980;6:497-503
pubmed: 7386283
Cell. 1993 Jan 29;72(2):269-78
pubmed: 8381049
Cell. 2005 Aug 12;122(3):379-91
pubmed: 16096058
Blood. 2006 Nov 1;108(9):3027-34
pubmed: 16857990
Blood. 2005 Nov 15;106(10):3410-4
pubmed: 16020504
Br J Haematol. 2014 Apr;165(2):227-36
pubmed: 24499183
Am J Cardiol. 1999 May 6;83(9A):3E-6E
pubmed: 10357574
Blood. 2015 May 7;125(19):2995-3005
pubmed: 25824689
J Thromb Haemost. 2020 May;18(5):1183-1196
pubmed: 31997536
J Biol Chem. 2016 Feb 12;291(7):3455-67
pubmed: 26668315
J Immunol. 2017 Feb 15;198(4):1638-1648
pubmed: 28087669
Nat Cell Biol. 2019 Dec;21(12):1590-1603
pubmed: 31740775
Blood Cells Mol Dis. 2006 Mar-Apr;36(2):99-103
pubmed: 16464622
J Cell Biol. 2013 Jun 10;201(6):785-96
pubmed: 23751492
EMBO J. 1999 Jan 4;18(1):270-9
pubmed: 9878069
J Cell Biochem. 2019 Sep;120(9):14201-14212
pubmed: 31074051
J Thromb Haemost. 2006 Mar;4(3):638-47
pubmed: 16460446
Hypertension. 1998 Jan;31(1 Pt 2):152-61
pubmed: 9453296
Biol Reprod. 2010 Oct;83(4):607-15
pubmed: 20574055
Semin Thromb Hemost. 2016 Apr;42(3):183-4
pubmed: 27023375
Cancer Res. 2019 Apr 1;79(7):1646-1657
pubmed: 30659022
Am J Physiol Gastrointest Liver Physiol. 2008 Feb;294(2):G452-9
pubmed: 18032482
J Thromb Haemost. 2021 Dec;19(12):2997-3007
pubmed: 34431201
J Biol Chem. 1995 Oct 27;270(43):25885-92
pubmed: 7592775
J Biol Chem. 2000 Dec 1;275(48):37542-51
pubmed: 10978317
J Thromb Haemost. 2018 Jun;16(6):1211-1225
pubmed: 29575487
Nat Commun. 2018 Jun 25;9(1):2459
pubmed: 29941989
Thromb Haemost. 2000 Apr;83(4):610-6
pubmed: 10780326
Immunity. 2005 Aug;23(2):177-89
pubmed: 16111636
Sci Rep. 2018 Jan 11;8(1):498
pubmed: 29323256
Thromb Res. 2003;111(1-2):65-73
pubmed: 14644082
Free Radic Biol Med. 2005 Mar 1;38(5):631-43
pubmed: 15683719
J Biol Chem. 2015 May 1;290(18):11557-68
pubmed: 25767114
J Nat Prod. 2020 Oct 23;83(10):2967-2975
pubmed: 33026809
Nat Med. 2013 Dec;19(12):1609-16
pubmed: 24216752
Curr Opin Hematol. 2012 Sep;19(5):385-91
pubmed: 22814651
J Leukoc Biol. 2013 Oct;94(4):693-703
pubmed: 23401599
Science. 2016 Jun 17;352(6292):1413-6
pubmed: 27313038
J Biol Chem. 2012 Dec 7;287(50):42352-60
pubmed: 23074222
J Neurooncol. 2017 Feb;131(3):485-493
pubmed: 27900644
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12097-102
pubmed: 19574459
J Neurosci. 2018 Feb 21;38(8):2118-2133
pubmed: 29367404
Blood. 2019 May 9;133(19):2013-2026
pubmed: 30723081
Genes Dev. 2007 Dec 15;21(24):3232-7
pubmed: 18055695
Cell. 2015 Jul 2;162(1):59-71
pubmed: 26095252
FASEB J. 2015 Nov;29(11):4568-78
pubmed: 26183771
EMBO J. 1997 Apr 15;16(8):1921-33
pubmed: 9155018
Prostaglandins Leukot Essent Fatty Acids. 2004 Apr;70(4):373-6
pubmed: 15041029
Eur J Med Chem. 2021 Jul 5;219:113420
pubmed: 33892273
Blood. 2019 Sep 19;134(12):911-923
pubmed: 31366617
J Biol Chem. 1998 Feb 20;273(8):4449-58
pubmed: 9468497
J Thromb Haemost. 2019 Mar;17(3):511-524
pubmed: 30632265
Blood. 2021 Aug 5;138(5):401-416
pubmed: 33895821
Cell Signal. 2016 Oct;28(10):1555-62
pubmed: 27418099
Translation (Austin). 2016 Aug 10;4(2):e1220899
pubmed: 28090419
Biochem Biophys Res Commun. 2016 Sep 16;478(2):893-9
pubmed: 27520370
Mol Cell Biol. 2004 Aug;24(15):6539-49
pubmed: 15254222
Elife. 2020 Nov 02;9:
pubmed: 33135632
Eur J Biochem. 1997 May 1;245(3):751-9
pubmed: 9183015
Thromb Haemost. 2015 Nov;114(5):969-81
pubmed: 26202144
J Med Chem. 2018 May 24;61(10):4348-4369
pubmed: 29683667
Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1829-36
pubmed: 23723374
Int J Mol Sci. 2020 Jun 05;21(11):
pubmed: 32517051
J Thromb Haemost. 2015 Jun;13 Suppl 1:S26-32
pubmed: 26149034
Oncotarget. 2016 Oct 11;7(41):66851-66864
pubmed: 27588477
Blood. 2014 Apr 17;123(16):e37-45
pubmed: 24523238
Genes Dev. 2004 Mar 15;18(6):660-72
pubmed: 15075293
Mol Cell Biol. 2001 Aug;21(16):5500-11
pubmed: 11463832
Cancers (Basel). 2019 Mar 03;11(3):
pubmed: 30832411
Blood. 2017 Apr 27;129(17):e38-e48
pubmed: 28213379
Sci Rep. 2016 Apr 18;6:23476
pubmed: 27087055
Rinsho Byori. 1979;Suppl 40:122-9
pubmed: 551220
Cancer Chemother Pharmacol. 2021 Jan;87(1):85-93
pubmed: 33159561
Cold Spring Harb Perspect Biol. 2019 May 1;11(5):
pubmed: 30037969

Auteurs

Bhanu Kanth Manne (BK)

University of Utah Molecular Medicine Program, Salt Lake City, UT.

Robert A Campbell (RA)

University of Utah Molecular Medicine Program, Salt Lake City, UT.
Department of Internal Medicine, University of Utah Health, Salt Lake City, UT.
Department of Pathology, University of Utah Health, Salt Lake City, UT.

Seema Bhatlekar (S)

University of Utah Molecular Medicine Program, Salt Lake City, UT.

Abigail Ajanel (A)

University of Utah Molecular Medicine Program, Salt Lake City, UT.
Department of Pathology, University of Utah Health, Salt Lake City, UT.

Frederik Denorme (F)

University of Utah Molecular Medicine Program, Salt Lake City, UT.

Irina Portier (I)

University of Utah Molecular Medicine Program, Salt Lake City, UT.

Elizabeth A Middleton (EA)

University of Utah Molecular Medicine Program, Salt Lake City, UT.
Department of Internal Medicine, University of Utah Health, Salt Lake City, UT.

Neal D Tolley (ND)

University of Utah Molecular Medicine Program, Salt Lake City, UT.

Yasuhiro Kosaka (Y)

University of Utah Molecular Medicine Program, Salt Lake City, UT.

Emilie Montenont (E)

University of Utah Molecular Medicine Program, Salt Lake City, UT.

Li Guo (L)

University of Utah Molecular Medicine Program, Salt Lake City, UT.

Jesse W Rowley (JW)

University of Utah Molecular Medicine Program, Salt Lake City, UT.
Department of Internal Medicine, University of Utah Health, Salt Lake City, UT.

Paul F Bray (PF)

University of Utah Molecular Medicine Program, Salt Lake City, UT.
Department of Internal Medicine, University of Utah Health, Salt Lake City, UT.

Shancy Jacob (S)

University of Utah Molecular Medicine Program, Salt Lake City, UT.

Rikiro Fukanaga (R)

Department of Biochemistry, Osaka University of Pharmaceutical Sciences, Osaka, Japan.

Christopher Proud (C)

Lifelong Health, South Australian Health & Medical Research Institute, Adelaide, Australia.
Department of Biological Sciences, University of Adelaide, Adelaide, Australia.

Andrew S Weyrich (AS)

University of Utah Molecular Medicine Program, Salt Lake City, UT.
Department of Internal Medicine, University of Utah Health, Salt Lake City, UT.

Matthew T Rondina (MT)

University of Utah Molecular Medicine Program, Salt Lake City, UT.
Department of Internal Medicine, University of Utah Health, Salt Lake City, UT.
Department of Pathology, University of Utah Health, Salt Lake City, UT.
Department of Internal Medicine and the Geriatric Research, Education, and Clinical Center (GRECC), George E. Wahlen Veterans Affairs Medical Center (VAMC), Salt Lake City, UT.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH